NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Biophytis SA (PA: ALBPS)

 
ALBPS Technical Analysis
5
As on 9th Jun 2023 ALBPS STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.17 & Strong Sell for SHORT-TERM with Stoploss of 0.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALBPSSTOCK Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month -0.01 -33.33
Volume 1435462 1 Year -0.47 -95.92
52 Week High 0.49 | 52 Week Low 0.02
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
ALBPS
Daily Charts
ALBPS
Intraday Charts
Whats New @
Bazaartrend
ALBPS
Free Analysis
 
ALBPS Important Levels Intraday
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
 
ALBPS Forecast April 2024
4th UP Forecast0.41
3rd UP Forecast0.28
2nd UP Forecast0.21
1st UP Forecast0.13
1st DOWN Forecast-0.09
2nd DOWN Forecast-0.17
3rd DOWN Forecast-0.24
4th DOWN Forecast-0.37
 
ALBPS Weekly Forecast
4th UP Forecast0.08
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.00
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.04
 
ALBPS Forecast2024
4th UP Forecast0.93
3rd UP Forecast0.64
2nd UP Forecast0.46
1st UP Forecast0.28
1st DOWN Forecast-0.24
2nd DOWN Forecast-0.42
3rd DOWN Forecast-0.6
4th DOWN Forecast-0.89
 
 
ALBPS Other Details
Segment EQ
Market Capital 68366400.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALBPS Address
ALBPS
 
ALBPS Latest News
 
Your Comments and Response on Biophytis SA
 
ALBPS Business Profile
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. Address: Sorbonne University, Paris, France, 75005
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service